Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

NCT07317505

Conditions: Cancer, Cancer (Solid Tumors), Colonic Diseases, +24 more
Locations: Carolina BioOncology Institute Huntersville, North Carolina, United States

NEXT Dallas Dallas, Texas, United States

NEXT Virginia Fairfax, Virginia, United States

View Trial Details

Recruiting

Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma

NCT07349303

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Recruiting

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

NCT06199713

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
Locations: University of Wisconsin Hospitals and Clinics (UWHC) Madison, Wisconsin, United States

View Trial Details

Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study

NCT07318051

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +61 more
Locations: Natera, Inc. Austin, Texas, United States

View Trial Details

Recruiting

Institutional Registry of Rare Diseases

NCT06573723

Conditions: Abnormalities, Multiple, Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, +144 more
Locations: Hospital Italiano de Buenos Aires Buenos Aires, Argentina

View Trial Details

Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

NCT06887348

Conditions: Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +20 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Tasman Oncology Research Southport, Queensland, Australia

View Trial Details

Recruiting

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

NCT03829254

Conditions: Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Cambridge University Hospitals NHS Foundation Trust (Addenbrookes Hospital) Cambridge, United Kingdom

Edinburgh Cancer Centre, Western General Hospital Edinburgh, United Kingdom

The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

University College London Hospital London, United Kingdom

View Trial Details

Recruiting

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

NCT07161310

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: Universitätsklinikum Frankfurt, Medizinische Klinik II, Hämatologie/Onkologie Frankfurt, Germany

View Trial Details

Recruiting

ACTengine® IMA203 Combined With mRNA-4203

NCT06946225

Conditions: Cutaneous Melanoma, Melanoma, Neoplasms, +15 more
Locations: University of California San Francisco San Francisco, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma

NCT07280832

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: BeiJing Cancer Hospital EC Beijing, Beijing Municipality, China

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions